HMO(Human Milk Oligosaccharides) 시장 규모, 점유율, 성장 분석 : 유형별, 제품 유형별, 용도별, 유통경로별, 지역별 - 업계 예측(2026-2033년)

Human Milk Oligosaccharides (HMO) Market size was valued at USD 229.64 Million in 2024 and is poised to grow from USD 253.3 Million in 2025 to USD 554.93 Million by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

The Human Milk Oligosaccharides (HMO) market is gaining traction as a crucial aspect of infant wellness and nutrition. These naturally occurring complex carbohydrates found in breast milk offer significant health benefits, promoting the development of the infant's immune system, gastrointestinal function, and cognitive skills. Increased awareness of their advantages fuels demand, particularly for infant formulas that aim to mimic breast milk. This growth aligns with a broader consumer trend toward seeking natural and holistic health solutions. Additionally, potential applications for HMOs extend beyond infant nutrition into pharmaceuticals, functional foods, and prebiotics. However, the complexity and high costs associated with HMO production, coupled with regulatory and intellectual property challenges, present hurdles that must be navigated to fully realize market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Human Milk Oligosaccharides (HMO) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Human Milk Oligosaccharides (HMO) Market Segments Analysis

Global Human Milk Oligosaccharides (HMO) Market is segmented by Type, Product, Application, Distribution channel and region. Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL and 6'SL. Based on Product, the market is segmented into Fucosyllactose, Lnt & LNnt and Sialyllactose. Based on Application, the market is segmented into Infant formula, Functional food & beverages, Food supplements, Health ingredients for human and animal and Other. Based on Distribution channel, the market is segmented into Hypermarkets and supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental stores, Mono-brand stores, Specialty stores and Online sales channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Human Milk Oligosaccharides (HMO) Market

The increasing recognition of the health benefits associated with human milk oligosaccharides (HMOs) is a significant catalyst for market growth. As consumers become more informed about the essential role HMOs play in enhancing immune function, supporting cognitive development, and improving gut health in infants, the demand for HMO-fortified products continues to rise. Additionally, the potential advantages of HMOs for adults are further boosting interest and consumption. This growing awareness is driving manufacturers to innovate and incorporate HMOs into a variety of products, ultimately catering to the health-conscious market and expanding the overall HMO market landscape.

Restraints in the Human Milk Oligosaccharides (HMO) Market

The Human Milk Oligosaccharides (HMO) market faces significant challenges due to the intricate and challenging processes involved in HMO synthesis. The complexity of these procedures not only makes them difficult to execute but also hampers the scalability and cost-effectiveness of HMO manufacturing. Replicating the diverse array of HMO structures found in breast milk requires substantial resources and expertise, which can result in higher production costs. These factors can limit market growth and accessibility, making it difficult for manufacturers to meet demand while maintaining affordability and efficiency in their production processes.

Market Trends of the Human Milk Oligosaccharides (HMO) Market

The Human Milk Oligosaccharides (HMO) market is witnessing a significant shift as research explores their applications beyond infant nutrition. While traditionally associated with breastfeeding, there is a growing trend to utilize HMOs in functional foods, dietary supplements, and therapeutics aimed at addressing various health concerns across diverse age groups. This expanded focus highlights the versatility of HMOs in enhancing gut health, boosting immune response, and potentially mitigating chronic diseases. As the understanding of HMO benefits evolves, their incorporation into mainstream health products is likely to accelerate, creating new opportunities and driving market growth in the functional food and health supplement sectors.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Human Milk Oligosaccharides (HMO) Market Size by Type & CAGR (2026-2033)

• Market Overview
• 2'FL
• 3'FL
• 3'SL
• 6'SL

Global Human Milk Oligosaccharides (HMO) Market Size by Product & CAGR (2026-2033)

• Market Overview
• Fucosyllactose
• Lnt & LNnt
• Sialyllactose

Global Human Milk Oligosaccharides (HMO) Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infant formula
• Functional food & beverages
• Food supplements
• Health ingredients for human and animal
• Other

Global Human Milk Oligosaccharides (HMO) Market Size by Distribution channel & CAGR (2026-2033)

• Market Overview
• Hypermarkets and supermarkets
• Drug store or pharmacy
• Mass merchandiser
• Departmental stores
• Mono-brand stores
• Specialty stores
• Online sales channel

Global Human Milk Oligosaccharides (HMO) Market Size & CAGR (2026-2033)

• North America (Type, Product, Application, Distribution channel)
  • US
  • Canada
• Europe (Type, Product, Application, Distribution channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Application, Distribution channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Application, Distribution channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Application, Distribution channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inbiose NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gnubiotics Sciences S.A (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal FrieslandCampina N.V (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elicityl S.A (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dextra Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycom A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycosyn (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medolac Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neolacta Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jennewein Biotechnologie GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Specialty Ingredients (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kirin Holdings Company (Kyowa Hakko Bio) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZuChem Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations